Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Comparing methods for managing blood pressure during heart surgery

Official title: Mean Arterial Pressure (MAP) Trial: Study Protocol for a Multicenter, Randomized, Controlled Trial to Compare Three Different Strategies of Mean Arterial Pressure Management During Cardiopulmonary By-pass

Run by Azienda Ospedaliera Universitaria Integrata Verona · NCT05740397 · Data updated 2026-11-12

This study is testing different ways to manage blood pressure during heart surgery to see which method helps patients recover better and avoid complications.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment900 (estimated)
SponsorAzienda Ospedaliera Universitaria Integrata Verona
Academic / other
Locations1 site (Verona)
StatusRecruiting
StartedMay 3, 2021
Main results expectedDecember 31, 2023
Study endsDecember 31, 2026
Registry record updatedFebruary 23, 2023
Trial IDNCT05740397 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 to 80 undergoing elective cardiac surgeries with a low surgical risk and preserved heart function.

Probably not a fit

Patients who may not benefit from this study include those requiring emergency surgeries, reoperations, or those with high surgical risk scores.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial aims to evaluate different strategies for managing Mean Arterial Pressure (MAP) during cardiopulmonary bypass (CPB) in cardiac surgery. It will be the first multicenter, randomized, controlled study to compare three distinct MAP management approaches to determine the most effective strategy for maintaining organ perfusion and preventing postoperative complications. The study will include patients undergoing elective heart surgeries with specific eligibility criteria, ensuring a controlled environment for assessing outcomes. By analyzing the effects of varying MAP levels, the trial seeks to establish updated guidelines for CPB management based on contemporary practices and technologies.

Why it matters

Potential benefit: If successful, this study could lead to improved patient outcomes by optimizing blood pressure management during heart surgeries, potentially reducing complications and enhancing recovery.

How similar studies have gone: While few single-center studies have explored MAP management during CPB, this multicenter approach is novel and aims to resolve existing contradictions in previous findings.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Elective surgery
* Index of surgical risk Euroscore II \< 9%
* The following procedures will be considered: Isolated or combined with aortic or mitral valve surgery coronary artery bypass graft surgery for acute or chronic coronary artery disease isolated aortic valve replacement for aortic stenosis and/or aortic regurgitation ; isolated mitral valve repair or replacement for mitral stenosis and/or mitral regurgitation; isolated ascending aorta surgery with or without aortic valve replacement
* Surgical approach through complete and/or mini-sternotomy
* Preserved or mildly reduced left ventricular ejection fraction (LVEF ≥ 40%) at preoperative echocardiography
* Patients with an estimated Glomerular filtration rate (eGFR) ≥ 40 ml/min/mq calculated using the Modification of Diet in Renal Disease formula (MDRD)
* Signed informed consent

Exclusion Criteria:

* Age \< 18 years and \>80 years
* Reoperation
* Emergent, urgent and salvage procedures
* Euroscore II \> 9%
* Right toracothomy procedures
* Any surgical procedure not listed above (i.e. tricuspid valve surgery, aortic root surgery, congenital heart diseases, surgery necessitating hypotermic circulation arrest, surgical ablation of atrial fibrillation etc.)
* More than mild left ventricular dysfunction at preoperative echocardiogram (LVEF \< 40%)
* Patients with critical preoperative state: any ventricular fibrillation or ventricular tachycardia, preoperative cardiac massage, preoperative ventilation before anaesthetic room, preoperative inotropes or mechanical circulatory support planned before cardiac intervention (i.e. during coronary angiography) and other conditions according to Euroscore II definition.
* Patients with an estimated eGFR \< 40 ml/min/mq calculated using the MDRD or patients on dialysis.
* Patients with chronic obstructive pulmonary disease \> 3 stage according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2019 classification.
* Patients with severe preoperative epatic failure (CHILD-PUGH ≥ B)
* Patient with severe symptomatic carotid atheromasia

Where it's running

  • Azienda Ospedaliera Universitaria Integrata di Verona
    Verona, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.